IRIS - Res&Arch Institutional Research Information System - Research & Archive

SCHIAROLI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.830
EU - Europa 1.031
AS - Asia 654
SA - Sud America 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.820
IE - Irlanda 374
SG - Singapore 316
IT - Italia 299
HK - Hong Kong 134
CN - Cina 128
UA - Ucraina 55
RU - Federazione Russa 53
DE - Germania 48
SE - Svezia 45
FI - Finlandia 44
VN - Vietnam 40
GB - Regno Unito 37
FR - Francia 19
KR - Corea 16
AT - Austria 14
BE - Belgio 11
NL - Olanda 10
CH - Svizzera 9
CA - Canada 8
TR - Turchia 7
PL - Polonia 4
CZ - Repubblica Ceca 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CL - Cile 2
ES - Italia 2
GR - Grecia 2
ID - Indonesia 2
IN - India 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
LB - Libano 1
MX - Messico 1
PH - Filippine 1
RO - Romania 1
ZA - Sudafrica 1
Totale 3.524
Salva come PNG Salva come JPEG
Città #
Dublin 374
Chandler 318
Singapore 250
San Mateo 169
Hong Kong 134
Boardman 126
Santa Clara 119
Altamura 116
Perugia 95
Dearborn 94
Medford 83
Princeton 83
Lawrence 80
Ann Arbor 55
Wilmington 55
Andover 51
Beijing 40
Dong Ket 39
Falls Church 30
Des Moines 24
Redmond 22
Los Angeles 20
New York 17
Saint Petersburg 17
Munich 16
Seoul 16
Helsinki 15
San Paolo di Civitate 14
Norwalk 13
Florence 12
Jacksonville 12
Brussels 11
Woodbridge 9
Bastia umbra 8
Rome 8
Ottawa 7
Redwood City 7
Espoo 6
Houston 6
Izmir 6
Amsterdam 5
Ashburn 5
Hefei 5
Moscow 5
Nanjing 5
Nanning 5
Ningbo 5
Vienna 5
Chicago 4
Den Haag 4
Jinan 4
Kunming 4
Lappeenranta 4
Milan 4
Nuremberg 4
Shanghai 4
Dallas 3
Nanchang 3
Tappahannock 3
Blanes 2
Cambridge 2
Dubai 2
Fairfield 2
Falkenstein 2
Guangzhou 2
Lausanne 2
London 2
Menlo Park 2
Naples 2
Pianello Val Tidone 2
San Diego 2
Sinalunga 2
Trieste 2
West Jordan 2
Aachen 1
Alcamo 1
Baku 1
Baoding 1
Bari 1
Basra 1
Bisaccia 1
Bogotá 1
Bologna 1
Brescia 1
Bryanston 1
Cairo 1
Clifton 1
Edinburgh 1
Favara 1
Figline Valdarno 1
Grimmen 1
Groningen 1
Hengyang 1
Huzhou 1
Jakarta 1
Kashan 1
Kiev 1
Landshut 1
Liberty 1
Ludwigshafen am Rhein 1
Totale 2.714
Salva come PNG Salva come JPEG
Nome #
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 89
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 80
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 67
Effects of antiretroviral therapy on lipid and immunovirological profile: Focus on proprotein convertase subtilisin/kexin 9 67
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 65
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy. 64
Biochemical markers of bone turnover and calcium dietary intake evaluation in HIV-infected patients 63
A nutraceutical combination targeting dyslipidemia and subclinical inflammation in HIV patients on stable antiretroviral therapy 63
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 60
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 59
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 58
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 58
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 57
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 57
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 57
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 56
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 53
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 52
Reactivation of hepatitis B virus replication due to cytotoxic therapy:a five-year prospective study 51
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 51
Bone-turnover markers in white HIV-infected patiens treated with or without TDF-containg regimens 49
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 48
Percutaneous vertebroplasty improves pain control and quality of life in patients suffering from back pain: A single center experience 48
Diagnosis of Nocardia paucivorans central nervous system infection by DNA sequencing from paraffin-embedded tissue 47
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 47
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 46
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study 45
Seroprevalence of anti-SARS-CoV2 antibodies in umbrian persons living with HIV 45
Effects of antiretroviral therapy on proprotein convertase subtilisin/kexin 9: focus on lipids, inflammation and immunovirological parameters 44
The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy 44
Prevalence of smoking and nicotine dependence in HIV patients, the project STOPS HIV from Italy 43
Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital. 43
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 43
Meningitis with cranial polyneuritis and cavernous sinus thrombosis by Borrelia crocidurae: First autochthonous case in Europe 41
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 41
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 41
Gangrenous Chickenpox with Atypical Clinical and Histopathological Findings. 40
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 40
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 39
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 39
NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial 38
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 37
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 37
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm 37
Genetic mechanisms of critical illness in COVID-19 37
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 37
Lingual tubercolosis: a rare disease in western countries 36
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 36
Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalized patients with covid-19 36
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 35
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 35
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 35
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 35
Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy 34
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: A cross-sectional analysis 34
Is the rate of virological failure to cART continuing to decline in recent calendar years? 34
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 34
Validation of a self-reported HIV symptoms list: The ISS-HIV symptoms scale 33
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 33
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 32
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 32
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort 32
Early treatment with bamlanivimab alone does not prevent COVID-19 hospitalization and its post-acute sequelae. A real experience in Umbria, Italy 32
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 30
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 30
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 30
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 29
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 29
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 29
Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate 28
Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy 28
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 28
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 27
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 27
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 26
An explainable model of host genetic interactions linked to COVID-19 severity 25
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 25
Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism 24
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 24
Transgender people living with HIV: characteristics and comparison to homosexual and heterosexual cisgender patients in two Italian teaching hospitals 24
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 24
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 24
Nelfinavir: An Old Ally in the COVID-19 Fight? 22
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 22
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir 22
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 21
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication 20
Whole-genome sequencing reveals host factors underlying critical COVID-19 20
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 20
Mapping the human genetic architecture of COVID-19 20
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 20
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 19
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 17
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 16
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 16
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 15
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 15
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 14
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies 14
A first update on mapping the human genetic architecture of COVID-19 11
Totale 3.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020174 0 0 0 0 0 0 64 14 30 50 7 9
2020/2021270 3 7 11 13 123 8 9 21 21 6 8 40
2021/2022663 29 120 5 12 27 17 14 179 30 47 94 89
2022/20231.266 88 269 17 109 94 106 9 39 473 0 36 26
2023/2024515 27 71 20 8 7 3 134 4 28 29 102 82
2024/2025604 26 134 65 63 215 85 16 0 0 0 0 0
Totale 3.801